Ionis Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2008 | $212.0M | $198.4M | $13.7M | $15.1M |
| FY2009 | $-108.4M | $-121.9M | $13.4M | $13.4M |
| FY2010 | $-63.6M | $-76.8M | $13.2M | $12.2M |
| FY2011 | $-114.8M | $-125.0M | $10.2M | $9.8M |
| FY2012 | $1.9M | $397.0K | $1.5M | $8.6M |
| FY2013 | $63.5M | $61.9M | $1.6M | $11.4M |
| FY2014 | $6.3M | $-1.2M | $7.5M | $31.4M |
| FY2015 | $21.1M | $13.4M | $7.7M | $59.3M |
| FY2016 | $-112.1M | $-119.2M | $7.1M | $72.1M |
| FY2017 | $174.1M | $139.4M | $34.8M | $86.0M |
| FY2018 | $602.9M | $589.3M | $13.6M | $131.3M |
| FY2019 | $345.6M | $314.7M | $30.9M | $146.6M |
| FY2020 | $35.9M | $772.0K | $35.1M | $230.1M |
| FY2021 | $30.8M | $18.8M | $12.0M | $120.7M |
| FY2022 | $-274.4M | $-290.1M | $15.7M | $100.3M |
| FY2023 | $-307.5M | $-331.3M | $23.8M | $105.8M |
| FY2024 | $-500.9M | $-546.2M | $45.3M | $130.2M |
| FY2025 | $-268.6M | $-320.0M | $51.4M | $133.9M |